Treatment response prediction with circulating tumor cell-derived organoids for soft tissue sarcoma.
Identification of novel actionable SNVs using targeted comprehensive genome profiling in patients with sarcoma. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does ...
Hemoglobin levels, transfusion independence, and low serum erythropoietin levels were all deemed to have a statistically significant relationship with erythropoiesis-stimulating agent (ESA) response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback